Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Health Economics & Costs

Saturday Links

Posted on February 18, 2023February 19, 2023 by John C. Goodman
  • The (health ) case against homelessness.
  • Lead poisoning is a worldwide problem.
  • The negative relationship between obesity and income is almost entirely driven by women. The relationship between income and weight is flat for men.
  • Finally the press gets its comeuppance in the Columbia Journalism Review for promoting the Trump-Russia hoax.
  • JAMA study: Medicare Advantage plans have higher quality and lower cost than traditional Medicare.
+

More Americans Delay Care Due to Cost

Posted on February 18, 2023February 19, 2023 by Devon Herrick

It’s no mystery that Americans are paying a bigger share of their medical bills out-of-pocket these days. Health plan deductibles have about doubled in the past two decades. My 2023 health plan deductible is nearly $9,000. Some family plans have combined deductibles of $15,000. High deductibles are causing more Americans to delay medical care according to The New York Times.

+

One-in-Ten FDA-Approved Drug Failed at Least One Drug Trial Goals

Posted on February 17, 2023 by Devon Herrick

Is U.S. Food and Drug Administration (FDA) approval the gold standard for whether a drug truly does what it’s supposed to? Not according to a recent analysis. A review by Harvard and Yale researchers found that one-in-ten drugs approved by the FDA between 2018-2021 failed one or more of the stated endpoints.

+

Thursday Links

Posted on February 16, 2023 by John C. Goodman
  • CBO: the US is on track to add $19 Trillion in new debt over the next ten years.
  • The US produces only 14% of the active pharmaceutical ingredients needed for generic drugs. India, China, and Italy are the top producers
  • Site neutral payments could save Medicare $150 billion over ten years. (And stop encouraging hospitals to buy up doctor practices.)
  • Are physician-owned hospitals the answer to hospital concentration?
  • John Cleese explains extremism.
+
  • Previous
  • 1
  • …
  • 337
  • 338
  • 339
  • 340
  • 341
  • 342
  • 343
  • …
  • 415
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom